Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FWGE Rx BioSCIENCE is a biotechnology company focused on the development and commercialization of medical-grade Fermented Wheat Germ Extract (FWGE) for oncology and immunology applications. The company's primary product, FWGE Rx, is a highly concentrated, gluten-free formulation of fermented wheat germ extract designed to support mitochondrial function and modulate the immune system in patients with chronic illnesses. By targeting metabolic pathways such as the pentose phosphate pathway and inhibiting enzymes like glucose-6-phosphate dehydrogenase, the company's therapies aim to deprive cancer cells of the precursors needed for DNA synthesis. FWGE Rx BioSCIENCE positions its products as adjunct therapies to standard-of-care treatments to improve patient outcomes and quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FWGE Rx BioSCIENCE.